Literature DB >> 32417933

Intrahepatic cholangiocarcinoma: pathogenesis, current staging, and radiological findings.

Mohammed Saleh1, Mayur Virarkar2, Vlad Bura3, Raul Valenzuela2, Sanaz Javadi2, Janio Szklaruk2, Priya Bhosale2.   

Abstract

To this date, it is a major oncological challenge to optimally diagnose, stage, and manage intrahepatic cholangiocarcinoma (ICC). Imaging can not only diagnose and stage ICC, but it can also guide management. Hence, imaging is indispensable in the management of ICC. In this article, we review the pathology, epidemiology, genetics, clinical presentation, staging, pathology, radiology, and treatment of ICC.

Entities:  

Keywords:  AJCC; CT; Cholangiocarcinoma; Intrahepatic; MRI; PET/CT

Mesh：

Year:  2020        PMID： 32417933     DOI： 10.1007/s00261-020-02559-7

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  86 in total

1.  Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study.

Authors:  Yasser H Shaib; Hashem B El-Serag; Jessica A Davila; Robert Morgan; Katherine A McGlynn
Journal:  Gastroenterology       Date:  2005-03       Impact factor: 22.682

Review 2.  Pathogenesis and classification of intrahepatic cholangiocarcinoma: different characters of perihilar large duct type versus peripheral small duct type.

Authors:  Shinichi Aishima; Yoshinao Oda
Journal:  J Hepatobiliary Pancreat Sci       Date:  2014-09-02       Impact factor: 7.027

3.  Global alterations of DNA methylation in cholangiocarcinoma target the Wnt signaling pathway.

Authors:  Benjamin Goeppert; Carolin Konermann; Christopher Roman Schmidt; Olga Bogatyrova; Lea Geiselhart; Christina Ernst; Lei Gu; Natalia Becker; Manuela Zucknick; Arianeb Mehrabi; Mohammadreza Hafezi; Frederick Klauschen; Albrecht Stenzinger; Arne Warth; Kai Breuhahn; Marcus Renner; Wilko Weichert; Peter Schirmacher; Christoph Plass; Dieter Weichenhan
Journal:  Hepatology       Date:  2013-12-24       Impact factor: 17.425

4.  Mutational landscape of intrahepatic cholangiocarcinoma.

Authors:  Shanshan Zou; Jiarui Li; Huabang Zhou; Christian Frech; Xiaolan Jiang; Jeffrey S C Chu; Xinyin Zhao; Yuqiong Li; Qiaomei Li; Hui Wang; Jingyi Hu; Guanyi Kong; Mengchao Wu; Chuanfan Ding; Nansheng Chen; Heping Hu
Journal:  Nat Commun       Date:  2014-12-15       Impact factor: 14.919

5.  Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection.

Authors:  Itaru Endo; Mithat Gonen; Adam C Yopp; Kimberly M Dalal; Qin Zhou; David Klimstra; Michael D'Angelica; Ronald P DeMatteo; Yuman Fong; Lawrence Schwartz; Nancy Kemeny; Eileen O'Reilly; Ghassan K Abou-Alfa; Hiroshi Shimada; Leslie H Blumgart; William R Jarnagin
Journal:  Ann Surg       Date:  2008-07       Impact factor: 12.969

Review 6.  Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma.

Authors:  Nestor F Esnaola; Joshua E Meyer; Andreas Karachristos; Jennifer L Maranki; E Ramsay Camp; Crystal S Denlinger
Journal:  Cancer       Date:  2016-01-22       Impact factor: 6.860

7.  Temporal trends in population-based death rates associated with chronic liver disease and liver cancer in the United States over the last 30 years.

Authors:  Yuhree Kim; Aslam Ejaz; Amit Tayal; Gaya Spolverato; John F P Bridges; Robert A Anders; Timothy M Pawlik
Journal:  Cancer       Date:  2014-06-10       Impact factor: 6.860

Review 8.  A review and update on cholangiocarcinoma.

Authors:  Matthew J Olnes; Rodrigo Erlich
Journal:  Oncology       Date:  2004       Impact factor: 2.935

9.  Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implications.

Authors:  Chaitanya R Churi; Rachna Shroff; Ying Wang; Asif Rashid; HyunSeon C Kang; Jacqueline Weatherly; Mingxin Zuo; Ralph Zinner; David Hong; Funda Meric-Bernstam; Filip Janku; Christopher H Crane; Lopa Mishra; Jean-Nicholas Vauthey; Robert A Wolff; Gordon Mills; Milind Javle
Journal:  PLoS One       Date:  2014-12-23       Impact factor: 3.240

Review 10.  Staging and Prognostic Models for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.

Authors:  Richard A Burkhart; Timothy M Pawlik
Journal:  Cancer Control       Date:  2017 Jul-Sep       Impact factor: 3.302
View more
  4 in total

1.  Utility of mean platelet volume in differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma.

Authors:  Xin Zhang; Wen-Juan Huang; Meng-Lin Zhang; Wen Wang; Ye Niu; Rui-Tao Wang; Zeng-Yao Liu
Journal:  BMC Gastroenterol       Date:  2022-06-06       Impact factor: 2.847

2.  The prognostic impact of lymphocyte-to-C-reactive protein score in patients undergoing surgical resection for intrahepatic cholangiocarcinoma: A comparative study of major representative inflammatory / immunonutritional markers.

Authors:  Daisuke Noguchi; Naohisa Kuriyama; Yuki Nakagawa; Koki Maeda; Toru Shinkai; Kazuyuki Gyoten; Aoi Hayasaki; Takehiro Fujii; Yusuke Iizawa; Akihiro Tanemura; Yasuhiro Murata; Masashi Kishiwada; Hiroyuki Sakurai; Shugo Mizuno
Journal:  PLoS One       Date:  2021-01-28       Impact factor: 3.240

3.  Chemokine (C-C motif) ligand 18/membrane-associated 3/forkhead box O1 axis promotes the proliferation, migration, and invasion of intrahepatic cholangiocarcinoma.

Authors:  Chusi Wang; Hao Liang; Yanjie Li; Zhaofeng Tang; Yingcai Zhang
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

Review 4.  Cholangiocarcinoma.

Authors:  Samantha Sarcognato; Diana Sacchi; Matteo Fassan; Luca Fabris; Massimiliano Cadamuro; Giacomo Zanus; Ivana Cataldo; Paola Capelli; Francesca Baciorri; Matilde Cacciatore; Maria Guido
Journal:  Pathologica       Date:  2021-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.